Empowering dialysis users and caregivers
Search for dialysis centres here
Log in to explore the world's most comprehensive database of dialysis centres for free!
Professional dialysis recruitment| Amgen to buy South San Francisco-based KAI Pharma for $315 million - pharmabiz.com |
 |
 |
|
pharmabiz.com KAI's lead product candidate, KAI-4169, is a novel agent being initially studied for the treatment of secondary hyperparathyroidism (SHPT) in patients with chronic kidney disease (CKD) who are on dialysis. SHPT, a component of CKD mineral and bone ... The Zacks Analyst Blog Highlights: The Goldman Sachs Group, Lloyd's, Bank of |
